Roche Holding AG (ROP) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.296x

Based on the latest financial reports, Roche Holding AG (ROP) has a cash flow conversion efficiency ratio of 0.296x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CHF11.23 Billion) by net assets (CHF37.88 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Roche Holding AG - Cash Flow Conversion Efficiency Trend (1998–2025)

This chart illustrates how Roche Holding AG's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Roche Holding AG Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Roche Holding AG ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
UnitedHealth Group Incorporated NYSE:UNH	0.011x
Kweichow Moutai Co Ltd SHG:600519	0.095x
Raytheon Technologies Corp NYSE:RTX	0.062x
G2EV34 SA:G2EV34	0.446x
Wells Fargo & Company NYSE:WFC	-0.005x
RTX Corporation NEO:RTX	N/A
Philip Morris International Inc NYSE:PM	-0.587x
Westpac Banking Corporation AU:WBCPI	-0.064x

Annual Cash Flow Conversion Efficiency for Roche Holding AG (1998–2025)

The table below shows the annual cash flow conversion efficiency of Roche Holding AG from 1998 to 2025.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CHF37.88 Billion	CHF17.83 Billion	0.471x	-15.29%
2024-12-31	CHF36.16 Billion	CHF20.09 Billion	0.556x	+14.84%
2023-12-31	CHF33.26 Billion	CHF16.09 Billion	0.484x	-13.41%
2022-12-31	CHF32.02 Billion	CHF17.89 Billion	0.559x	-22.99%
2021-12-31	CHF28.34 Billion	CHF20.57 Billion	0.726x	+58.93%
2020-12-31	CHF39.77 Billion	CHF18.16 Billion	0.457x	-26.84%
2019-12-31	CHF35.87 Billion	CHF22.39 Billion	0.624x	-5.14%
2018-12-31	CHF30.37 Billion	CHF19.98 Billion	0.658x	+5.89%
2017-12-31	CHF29.01 Billion	CHF18.02 Billion	0.621x	+9.36%
2016-12-31	CHF26.40 Billion	CHF15.00 Billion	0.568x	-13.20%
2015-12-31	CHF23.30 Billion	CHF15.25 Billion	0.655x	-11.42%
2014-12-31	CHF21.56 Billion	CHF15.93 Billion	0.739x	-0.48%
2013-12-31	CHF21.24 Billion	CHF15.77 Billion	0.743x	-17.22%
2012-12-31	CHF16.73 Billion	CHF15.01 Billion	0.897x	+0.28%
2011-12-31	CHF14.48 Billion	CHF12.95 Billion	0.894x	-27.27%
2010-12-31	CHF11.66 Billion	CHF14.34 Billion	1.230x	-31.40%
2009-12-31	CHF9.41 Billion	CHF16.88 Billion	1.793x	+692.39%
2008-12-31	CHF53.82 Billion	CHF12.18 Billion	0.226x	+2.83%
2007-12-31	CHF53.31 Billion	CHF11.73 Billion	0.220x	-0.29%
2006-12-31	CHF46.81 Billion	CHF10.33 Billion	0.221x	-7.67%
2005-12-31	CHF41.74 Billion	CHF9.97 Billion	0.239x	+8.46%
2004-12-31	CHF33.29 Billion	CHF7.33 Billion	0.220x	-11.41%
2003-12-31	CHF29.16 Billion	CHF7.25 Billion	0.249x	+552.72%
2002-12-31	CHF25.77 Billion	CHF982.00 Million	0.038x	-74.64%
2001-12-31	CHF33.87 Billion	CHF5.09 Billion	0.150x	+22.90%
2000-12-31	CHF32.04 Billion	CHF3.92 Billion	0.122x	+112.35%
1999-12-31	CHF30.00 Billion	CHF1.73 Billion	0.058x	-63.69%
1998-12-31	CHF22.82 Billion	CHF3.62 Billion	0.159x	--

About Roche Holding AG

SW:ROP Switzerland Drug Manufacturers - General

Market Cap

$278.72 Billion

CHF220.46 Billion CHF

Market Cap Rank

#64 Global

#1 in Switzerland

Share Price

CHF320.00

Change (1 day)

+2.07%

52-Week Range

CHF300.90 - CHF323.90

All Time High

CHF323.90